Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 17413054)

Published in Chest on April 05, 2007

Authors

Shalini Patel1, Armen E Parsyan, Julia Gunn, M Anita Barry, Carrie Reed, Sharon Sharnprapai, C Robert Horsburgh

Author Affiliations

1: Department of Medicine, Section of Infectious Diseases, School of Medicine, Boston University, Boston, USA.

Articles by these authors

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02

Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65

Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med (2011) 6.14

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med (2015) 6.04

The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86

Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med (2015) 4.90

High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis (2005) 4.45

Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses (2009) 4.02

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet (2002) 3.95

Endothelial function in HIV-infected persons. Clin Infect Dis (2006) 3.80

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis (2011) 3.46

Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis (2009) 2.56

Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis (2011) 2.40

Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis (2012) 2.38

Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38

Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med (2011) 2.36

The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am J Respir Crit Care Med (2006) 2.33

Pre-operative brain injury in newborn infants with transposition of the great arteries occurs at rates similar to other complex congenital heart disease and is not related to balloon atrial septostomy. J Am Coll Cardiol (2009) 2.28

Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med (2006) 2.23

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr (2005) 2.13

The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med (2015) 1.89

Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One (2013) 1.64

Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol (2010) 1.56

Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans. J Infect Dis (2013) 1.50

Use of a population-based survey to describe the health of Boston public housing residents. Am J Public Health (2007) 1.47

Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med (2006) 1.45

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS (2012) 1.40

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis (2013) 1.37

The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. Drug Alcohol Depend (2008) 1.33

Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico. PLoS One (2009) 1.33

Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol (2006) 1.31

Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy. AIDS (2003) 1.28

Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med (2010) 1.28

Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol (2013) 1.27

Treatment of Tuberculosis. N Engl J Med (2015) 1.25

Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems. AIDS (2008) 1.25

The severity of pandemic H1N1 influenza in the United States, April -- July 2009. PLoS Curr (2009) 1.15

Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009. PLoS One (2011) 1.15

Integration of a participatory research strategy into a rural health survey. J Gen Intern Med (2003) 1.14

A pilot study of treatment of Buruli ulcer with rifampin and dapsone. Int J Infect Dis (2002) 1.14

Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture. BMC Infect Dis (2008) 1.14

Human immunodeficiency virus infection in a rural community in the United States. Am J Epidemiol (2004) 1.12

Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study. Diabetes Care (2011) 1.11

Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection. Clin Infect Dis (2004) 1.11

Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.10

History of incarceration and gang involvement are associated with recent sexually transmitted disease/HIV diagnosis in African American men. J Acquir Immune Defic Syndr (2008) 1.09

Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis (2014) 1.05

Impact of genotyping of Mycobacterium tuberculosis on public health practice in Massachusetts. Emerg Infect Dis (2002) 1.04

Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012. Clin Infect Dis (2013) 1.04

Immunization registries: costs and savings. Public Health Rep (2002) 1.03

The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis (2013) 1.01

Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clin Infect Dis (2013) 1.00

Estimated costs of false laboratory diagnoses of tuberculosis in three patients. Emerg Infect Dis (2002) 1.00

Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. J Infect Dis (2010) 1.00

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. Vaccine (2010) 0.99

MoSAIC: Mobile Surveillance for Acute Respiratory Infections and Influenza-Like Illness in the Community. Am J Epidemiol (2014) 0.96

Predictors of failure to complete treatment for latent tuberculosis infection. J Infect (2006) 0.96

Transmission of 2009 pandemic influenza A (H1N1) at a Public University--Delaware, April-May 2009. Clin Infect Dis (2011) 0.95

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study. J Acquir Immune Defic Syndr (2014) 0.95

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One (2011) 0.94

Direct cost associated with the development and implementation of a local syndromic surveillance system. J Public Health Manag Pract (2007) 0.93

Risk factors for nonadherence with Pap testing in HIV-infected women. J Womens Health (Larchmt) (2011) 0.92

Recent cigarette smoking and HIV disease progression: no evidence of an association. AIDS Care (2011) 0.92

Transmissibility of variant influenza from Swine to humans: a modeling approach. Clin Infect Dis (2013) 0.90

Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. Emerg Infect Dis (2011) 0.89

Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22). Contemp Clin Trials (2006) 0.89

Hospital water as a source of Mycobacterium avium complex isolates in respiratory specimens. J Infect Dis (2003) 0.89

Using resident health advocates to improve public health screening and follow-up among public housing residents, Boston, 2007-2008. Prev Chronic Dis (2010) 0.89

Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease. J Clin Microbiol (2012) 0.88

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection. AIDS Patient Care STDS (2011) 0.87

Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization. PLoS One (2011) 0.86

The GirlStars program: challenges to recruitment and retention in a physical activity and health education program for adolescent girls living in public housing. Prev Chronic Dis (2010) 0.86

Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis. Clin Infect Dis (2012) 0.84

Respiratory syncytial virus and Staphylococcus aureus coinfection in children hospitalized with pneumonia. Pediatr Infect Dis J (2010) 0.84

Reinfection with Mycobacterium tuberculosis. Am J Respir Crit Care Med (2006) 0.84

Evaluation of exposure-specific risks from two independent samples: a simulation study. BMC Med Res Methodol (2011) 0.84

Local collaborations: development and implementation of Boston's bioterrorism surveillance system. J Public Health Manag Pract (2004) 0.82

Quality of hepatitis C care at an urban tertiary care medical center. J Health Care Poor Underserved (2014) 0.82

Health department costs of managing persons with suspected and noncounted tuberculosis in New York City, Three Texas counties, and Massachusetts. J Public Health Manag Pract (2006) 0.82

Multistate US Outbreak of Rapidly Growing Mycobacterial Infections Associated with Medical Tourism to the Dominican Republic, 2013-2014(1). Emerg Infect Dis (2016) 0.82

Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial. J Infect Dis (2006) 0.81

Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania. Tuberculosis (Edinb) (2013) 0.81

Encouraging news for multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med (2010) 0.80

Self-reported fever and measured temperature in emergency department records used for syndromic surveillance. J Am Med Inform Assoc (2012) 0.79

Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. J Infect Dis (2007) 0.79

Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clin Infect Dis (2013) 0.79

Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates. Emerg Infect Dis (2015) 0.79

Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus. Am J Public Health (2012) 0.79

Mortality hazard and survival after tuberculosis treatment. Am J Public Health (2015) 0.78

Diagnosing smallpox: would you know it if you saw it? Biosecur Bioterror (2004) 0.78

Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach. Am J Epidemiol (2014) 0.77

Laboratory-acquired vaccinia virus infection in a recently immunized person--Massachusetts, 2013. MMWR Morb Mortal Wkly Rep (2015) 0.77

Adolescent experiences of violence and relation to violence perpetration beyond young adulthood among an urban sample of Black and African American males. J Urban Health (2014) 0.76

Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis. J Infect Dis (2013) 0.76

Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons: what does the future hold in store? J Infect Dis (2008) 0.75

Another step on the path to better TB therapies. Int J Tuberc Lung Dis (2002) 0.75